# Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections

> **NCT06731790** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 35 (actual)

## Conditions studied

- Rare Genetic Disease
- Acute Necrotizing Encephalopathy

## Interventions

- **OTHER:** Blood sampling for inflammatory phenotype analysis
- **GENETIC:** Blood sampling for genetic analysis

## Key facts

- **NCT ID:** NCT06731790
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-24
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731790, "Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06731790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*